First attempts to block IL-1 have failed to show an adequate response in rheumatoid arthritis (RA), SLE, and osteoarthritis (18, 27), but IL-1 blockade has proven to be effective in the treatment of autoinflammatory diseases (21). This evidence concerns the gene IL1A and rheumatoid arthritis.